Dr. Reddys Laboratories Ltd.

Dr Reddys Laboratories is currently trading at Rs. 1901.00, up by 14.25 points or 0.76% from its previous closing of Rs. 1886.75 on the BSE.

The scrip opened at Rs. 1882.00 and has touched a high and low of Rs. 1910.00 and Rs. 1870.70 respectively. So far 4566 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1968.60 on 25-Jan-2013 and a 52 week low of Rs. 1528.00 on 19-Jun-2012.

Last one week high and low of the scrip stood at Rs. 1949.50 and Rs. 1875.00 respectively. The current market cap of the company is Rs. 32209.49 crore.

The promoters holding in the company stood at 25.56% while Institutions and Non-Institutions held 40.15% and 17.63% respectively.

Dr Reddy’s Laboratories has started withdrawing its muscle relaxant - tizanidine tablets, from the US market because of labeling issues. The entity has taken this decision after receiving the notification issued by United States Food and Drug Administration (FDA), and the same was intimated to the drug regulator through a letter on March 19.

The company has received the notification from FDA that, there is a possibility that the bottle labels do not contain the strength of the product as well as other printing details. Till the date 117,000 bottles are being recalled from the market by Dr Reddy’s Laboratories under a Class-III recall. The tablets are of 4 mg strength.